Application no. and date | 13723672.5 (espacenet) (Federated) (European Patent Register), 20130516 | Patent/reg. no. and date | DK/EP 2849745, 20171101 | Publication date | 20150325 | Priority no. and date | EP 12003935, 20120518 | EP pub. no. and date |
EP 2849745 20150325 | Effective date | | Applicant/owner | Grünenthal GmbH, Zieglerstrasse 6
52078 Aachen, DE | Applicant ref. no. | 160784 | Inventor | FROSCH, Stefanie, Beckerstrasse 49
52078 Aachen, DE, LINZ, Klaus, Nachtigallengrund 5
53359 Rheinbach, DE, SCHIENE, Klaus, Schaan 51 Jüchen
41363 Jüchen, DE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/192 (2006.01) , A61K 31/407 (2006.01) , A61K 45/06 (2006.01) , A61P 29/00 (2006.01) | Title | Farmaceutisk sammensætning omfattende (1r,4r)-6'-fluor-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyklohexan-1,1'-pyran-[3,4,b]indol]-4-amin og ibuprofen | Int. application no. | EP2013001466 | Int. publication no. | WO2013170967 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|